Results 91 to 100 of about 32,346 (218)

Differences on in-hospital outcomes in patients with cardiogenic shock due to STEMI vs NSTEMI using a nationwide database

(CM20/00104 y JR22/00004)Background Our study aims to compare in-hospital management and outcomes in patients with cardiogenic shock due to ST-segment elevation myocardial infarction (STEMI) vs.
Juárez Olmos, Víctor, Moreno Muñoz, Guillermo, Bueno Zamora, Héctor José, Vicent, Lourdes, Diaz Arocutipa, Carlos   +4 more
core   +1 more source

Frequency of Patients with NSTEMI Electrocardiographic Changes that Have Potential to Become STEMI [PDF]

, 2020
Acute Coronary Syndrome (ACS) can be divided into a subgroup of ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and Unstable Angina (UA). ACS carries significant morbidity and mortality and the
Suling, Frits R.W
core   +1 more source

Prognostic significance of the discrepancy between STEMI/NSTEMI paradigm and the angiographically confirmed diagnosis of Occlusion Myocardial Infarction: a retrospective cohort study

Heliyon
Background: It is commonly assumed that acute total occlusion of the infarct-related artery corresponds to the diagnosis of ST-elevation myocardial infarction (STEMI), yet growing evidence suggests that the ST-elevation/non–ST-elevation myocardial ...
Michał Terlecki, H. Pendell Meyers, Stephen W. Smith, Robert Herman, Maryla Kocowska-Trytko, Christopher Pavlinec, Emil Dadański, Łukasz Klima, Jakub Rusinek, Maciej Zając, Wojciech Wojakowski, Wiktoria Wojciechowska, Łukasz Rzeszutko, Stanisław Bartuś, Marek Rajzer   +14 more
doaj   +1 more source

Non–ST‐Segment–Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score–Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundChronic kidney disease (CKD) remains an independent predictor of cardiovascular morbidity and mortality. CKD complicates referral for percutaneous coronary intervention (PCI) in non–ST‐segment–elevation myocardial infarction (NSTEMI) patients ...
Subir Bhatia, Shilpkumar Arora, Sravya M. Bhatia, Mohammed Al‐Hijji, Yogesh N. V. Reddy, Parshva Patel, Charanjit S. Rihal, Bernard J. Gersh, Abhishek Deshmukh   +8 more
doaj   +1 more source

Benson Therapy Against Pain Scale in Patient with NSTEMI [PDF]

, 2023
Unstable Angina Pectoris is an attack of pain or stinging in the chest, one of which is NSTEMI disorder. The number of deaths due to heart attacks is obtained at a very high rate of around 17.7 million per year and 31% of deaths in the world. NSTEMI is a
Siwi, Adiratna Sekar, Setia Aji, Tatang Kurniawan, Widodo, Taat Agung   +2 more
core  

Long-Term Prognosis in Young Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention

Vascular Health and Risk Management, 2021
Oren Yagel,* Naseem Shadafny,* Ran Eliaz, Gil Dagan, David Leibowitz, Ilgar Tahiroglu, David Planer, Offer Amir, Gabby Elbaz Greener,* Ronny Alcalai* Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew ...
Yagel O, Shadafny N, Eliaz R, Dagan G, Leibowitz D, Tahiroglu I, Planer D, Amir O, Elbaz Greener G, Alcalai R   +9 more
doaj  

Treatment strategies of NSTEMI-ACS with multivessel disease

International Cardiovascular Forum Journal, 2016
Acute coronary syndrome (ACS) is caused when myocardial blood supply is acutely compromised, which results in prolonged chest pain. The common underlying mechanisms of ACS include erosion or sudden rupture of an atherosclerotic plaque within the wall of a coronary artery.
Bajraktari, Gani, Henein, Michael Y
openaire   +2 more sources

Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

Scientific Reports
The ST-elevation Myocardial Infarction (STEMI) and Non-ST-elevation Myocardial Infarction (NSTEMI) might occur because of coronary artery stenosis. The gene biomarkers apply to the clinical diagnosis and therapeutic decisions in Myocardial Infarction ...
Mohammad Elahimanesh, Nafiseh Shokri, Elmira Mahdinia, Payam Mohammadi, Najmeh Parvaz, Mohammad Najafi   +5 more
doaj   +1 more source

Angiopoietin-2 as a biomarker of non-ST-segment elevation myocardial infarction in patients with or without type 2 diabetes

Archives of Medical Science, 2019
Introduction Angiopoietin-2 (Ang-2) is a novel marker of coronary artery disease (CAD) and diabetes (DM). The aim was to evaluate Ang-2 as a potential new biomarker of non-ST elevation myocardial infarction (NSTEMI) in patients with or without type 2 DM (
Tomasz Skowerski, Katarzyna Nabrdalik, Hanna Kwiendacz, Maciej Pajak, Katarzyna Mizia-Stec, Zbigniew Gasior, Janusz Gumprecht   +6 more
doaj   +1 more source

European NSTEMI guidelines—return of clopidogrel? [PDF]

European Journal of Clinical Pharmacology, 2021
Lisa Dannenberg, René M’Pembele, Daniel Metzen, Tobias Petzold, Tobias Zeus, Malte Kelm, Amin Polzin   +6 more
openaire   +2 more sources